
MIFtek Inc. pioneers in next-gen cellular analysis solutions, integrating advanced photon detection tech for diagnostic tools.
miftek.comCrawled Oct 15, 2026
Miftek’s LIPS-405 uses 405 nm laser excitation for laser-induced fluorescence optics. Photon detection is used for material analysis and coating autofluorescence evaluation.
Miftek’s PDS-100 is a photon-counting system. GPS-10 integrates a SiPM, thermoelectric cooler, and GHz electronics; GPC-10 counts up to 1.8Gcps with 300ps pulse resolution, while CS-001 controls monochromator wavelengths in 0.1nm steps.
Miftek technology is unique. Over the past 40 years, cellular analysis has been focused on finding cells but the level of analysis is low. What is needed to move to the next generation of cell analysis is the ability to extract complex information from every cell every time.
Miftek’s SPS-100 is a single-photon spectrometer for 200–900 nm. Combined with the PDS-100 and a motorized monochromator, it evaluates intensity profiles across six orders of magnitude; CS-001 controls wavelength in 0.1 nm steps.
The work presents a prototype hyperspectral detection system for flow cytometers, evaluating fluorescence across 340–800 nm with 42 channels and 16-bit resolution.
The page contrasts top-hat and Gaussian laser illumination in flow cytometry, noting that top-hat illumination offers greater tolerance but lower spatial resolution, while Gaussian beams have higher spatial resolution and peak intensity.
Pixel-array silicon photomultipliers (SiPMs) have picosecond avalanche processes and can amplify millions of photoelectrons. Their quantum efficiency, small size, low bias voltage, and light durability suit biological applications, while limited dynamic range and high dark counts are drawbacks.
WEST LAFAYETTE, Ind. – Purdue University researchers pursuing a way to repurpose high-definition Blu-ray technology, popular for watching videos and listening to music, to diagnose early-stage cancers and monitor their treatments have received nearly $200,000 in state and federal grants.
MIFtek Inc. is an Indiana technology development company focused on single-photon technologies and microfluidics. It develops diagnostic tools and photon-detection devices for cellular analysis.
Miftek’s principals have over 75 years of experience, and their work represents over 200 issued patents. The company aims to develop cell-analysis tools and has R&D relationships with biophotonics companies.
The company integrates sensor capabilities with methods for analyzing cellular systems and their function. It develops single-photon sensors and high-speed electronics and aims to develop diagnostic tools.